Stay updated on Apremilast in Nummular Eczema Clinical Trial
Sign up to get notified when there's something new on the Apremilast in Nummular Eczema Clinical Trial page.

Latest updates to the Apremilast in Nummular Eczema Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant updates, including the removal of detailed study protocols and criteria for a clinical trial on nummular eczema, while retaining the study's location and collaborators. The version number has also been updated.SummaryDifference24%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoNo Change Detected
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference2%
- Check94 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Apremilast in Nummular Eczema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Apremilast in Nummular Eczema Clinical Trial page.